Geffken Daniel E.
- SEC CIK
- 0001314756
No open-market purchases or sales filed in the past year.
Current role at each company
- CALCCalciMedica, Inc.Interim CFOas of May 20, 2024
- CEROCero Therapeutics Holdings, Inc.Chief Financial Officeras of Feb 16, 2024
- PMNProMIS Neurosciences Inc.Chief Financial Officeras of Oct 30, 2023
- WINTWindtree Therapeutics IncDirectoras of Aug 29, 2023
- ELOXEloxx Pharmaceuticals, Inc.INTERIM CFOas of Dec 1, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Geffken Daniel E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ELOX Eloxx Pharmaceuticals, Inc.
INTERIM CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Geffken Daniel E.INTERIM CFO | PPurchase | +50.0K | $0.72 | +$36.0K | New position50.0K after |